Tedizolid Phosphate

Tedizolid phosphate is an antibiotic medication being studied in clinical trials for treating various bacterial infections. These trials are evaluating its safety, effectiveness, and optimal dosing across different patient populations, including adults, children, and those with specific conditions like skin infections or prosthetic joint infections. The studies are examining both oral and intravenous formulations of tedizolid phosphate to determine how it performs compared to other antibiotics and in different patient scenarios.

Related diseases and areas:

• Tuberculosis
• Haematological infection
• Pulmonary tuberculosis

TEDUGLUTIDE

Teduglutide is a medication that has been extensively studied for its effectiveness in treating Short Bowel Syndrome (SBS), a condition where patients have insufficient intestinal absorptive capacity, usually due to surgical removal of portions of the small intestine. These patients often depend on parenteral support (PS) – nutrition delivered directly into the bloodstream – for survival. Clinical trials have shown that teduglutide, which is similar to a naturally occurring hormone called glucagon-like peptide 2 (GLP-2), can enhance intestinal absorption, potentially reducing the need for parenteral nutrition. This article summarizes key findings from clinical trials examining teduglutide’s safety, efficacy, and impact on quality of life for patients with Short Bowel Syndrome.

Related diseases and areas:

• Short-bowel syndrome

Tegafur

Tegafur is an oral chemotherapy drug being investigated in various clinical trials for treating different types of cancer. As a prodrug of 5-fluorouracil (5-FU), tegafur is often combined with other medications to enhance its effectiveness and reduce side effects. This article summarizes key findings from recent clinical trials exploring tegafur’s potential in cancer treatment.

Related diseases and areas:

• Bile duct adenocarcinoma
• Breast cancer
• Pancreatic carcinoma metast…
• Rectal cancer recurrent

Telisotuzumab Vedotin

Telisotuzumab Vedotin, also known as ABBV-399, is an investigational drug being studied in clinical trials for the treatment of non-small cell lung cancer (NSCLC). This article explores the ongoing research on Telisotuzumab Vedotin, its potential benefits, and its role in addressing specific types of NSCLC, particularly those overexpressing the c-Met protein. The trials aim to assess the drug’s safety, efficacy, and potential combinations with other treatments to improve outcomes for patients with advanced NSCLC.

Related diseases and areas:

• Non-small cell lung cancer

Telitacicept

Telitacicept is an innovative drug being studied in clinical trials for various autoimmune conditions. This article summarizes the current research on Telitacicept’s potential to treat diseases like lupus, IgA nephropathy, and vasculitis by targeting B cells and reducing harmful antibody production.

Related diseases and areas:

• Myasthenia gravis

Telmisartan

This article explores the use of Telmisartan, also known as BIBR 277, in various clinical trials. These studies focus on comparing different formulations of Telmisartan, investigating its bioequivalence, and examining potential drug interactions. The trials involve healthy volunteers and patients with hypertension and nephropathy, providing valuable insights into the drug’s effectiveness and safety profile.

Related diseases and areas:

• Portal hypertension
• Peripheral arterial occlusi…
• Hypertension
• Colonoscopy
• Liver disorder
• Cardiac failure

Temocillin Sodium

This article summarizes several clinical trials investigating the use of temocillin sodium, an antibiotic, for treating various bacterial infections. The trials examine temocillin’s efficacy, safety, and pharmacokinetics in different patient populations and infection types, with a focus on its potential as an alternative to carbapenems for treating resistant bacteria.

Related diseases and areas:

• Pathogen resistance
• Bacterial infection

Temsirolimus

Temsirolimus, also known by its brand name Torisel, is a drug being studied in various clinical trials for its potential in treating different types of cancer. This article explores the use of temsirolimus in clinical trials, focusing on its efficacy, safety, and application in treating conditions such as renal cell carcinoma, mantle cell lymphoma, and other advanced cancers. The trials aim to evaluate the drug’s effectiveness, determine optimal dosing, and assess its impact on patients’ quality of life and survival rates.

Related diseases and areas:

• Neuroblastoma
• Inflammatory myofibroblasti…
• Rhabdomyosarcoma

Tenecteplase

Tenecteplase, a thrombolytic drug, is being extensively studied in clinical trials for its potential in treating acute ischemic stroke. These trials aim to evaluate its efficacy, safety, and optimal dosing compared to standard treatments. Researchers are exploring its use in various time windows after stroke onset and in combination with other therapies like endovascular thrombectomy.

Related diseases and areas:

• Ischaemic stroke
• Retinal artery occlusion

Tenofovir Disoproxil Fumarate

This article examines the use of Tenofovir Disoproxil Fumarate (TDF) in clinical trials for the treatment of chronic hepatitis B. TDF is an antiviral medication that has shown promise in suppressing hepatitis B virus (HBV) replication and improving liver health in patients with chronic HBV infection. The trials discussed here evaluate TDF’s efficacy, safety, and optimal dosing in various patient populations, including treatment-naïve patients, those who have failed previous therapies, and special groups like pregnant women. By reviewing these clinical studies, we can gain insights into TDF’s potential as a key treatment option for chronic hepatitis B.

Teplizumab

Teplizumab is an innovative drug being studied in clinical trials for its potential to delay or prevent the onset of type 1 diabetes (T1D). This article explores the use of teplizumab in various clinical trials, focusing on its efficacy, safety, and potential benefits for individuals at risk of developing T1D or those recently diagnosed with the condition.

Related diseases and areas:

• Diabetes mellitus

Tepotinib

Tepotinib is an investigational drug being studied in clinical trials for the treatment of various types of cancer, particularly non-small cell lung cancer (NSCLC) with specific genetic alterations. This article summarizes key findings from several clinical trials evaluating tepotinib’s safety, efficacy, and pharmacokinetics in cancer patients and healthy volunteers. The trials explore tepotinib as both a monotherapy and in combination with other drugs for patients with MET gene alterations and other biomarkers.

Related diseases and areas:

• Plasma cell myeloma
• Neoplasm malignant
• Lung neoplasm malignant
• Non-Hodgkin’s lymphoma
• Head and neck cancer
• Non-small cell lung cancer

Teprenone

Teprenone, also known as geranylgeranylacetone (GGA), is a drug that has been the subject of several clinical trials investigating its potential benefits in various medical conditions. These trials have primarily focused on its effects on gastric health, including the prevention of ulcers and treatment of gastritis, as well as its potential role in heart failure management. The studies aim to evaluate Teprenone’s efficacy, safety, and mechanisms of action in comparison to other treatments or placebos.

Related diseases and areas:

• Atrial fibrillation

Teprotumumab

Teprotumumab, also known as Tepezza, is a groundbreaking drug being studied in clinical trials for the treatment of Thyroid Eye Disease (TED). This article explores the various clinical trials investigating the efficacy, safety, and administration methods of teprotumumab in patients with TED and other conditions. We’ll delve into the drug’s potential benefits, its mechanism of action, and the ongoing research to optimize its use in medical practice.

Related diseases and areas:

• Endocrine ophthalmopathy

Terbinafine

This article examines the use of terbinafine, an antifungal medication, in various clinical trials. Terbinafine has been studied for treating conditions like onychomycosis (nail fungus), tinea pedis (athlete’s foot), and tinea capitis (scalp ringworm). The trials investigate different formulations, including oral tablets, topical creams, nail lacquers, and film-forming solutions. Researchers aim to assess the drug’s effectiveness, safety, and optimal treatment durations for these fungal infections.

Related diseases and areas:

• Chronic hepatitis B
• Onychomycosis

Terbinafine Hydrochloride

Terbinafine Hydrochloride, commonly known as Lamisil, is an antifungal medication that has been the subject of several clinical trials. These studies aim to evaluate its effectiveness, safety, and new delivery methods for treating various fungal infections, particularly onychomycosis (toenail fungus) and tinea capitis (scalp ringworm). The trials explore different formulations, including oral tablets, topical solutions, and innovative delivery systems, to improve treatment outcomes for patients with these persistent fungal conditions.

Related diseases and areas:

• Onychomycosis

Teriflunomide

Teriflunomide, marketed under the brand name Aubagio, is an oral medication that has shown promise in the treatment of multiple sclerosis (MS) and other autoimmune conditions. This article explores the use of teriflunomide in various clinical trials, examining its efficacy, safety, and potential benefits for patients with relapsing forms of MS and other disorders.

Related diseases and areas:

• Secondary progressive multi…
• Relapsing-remitting multipl…
• Progressive multiple sclerosis
• Relapsing multiple sclerosis
• Progressive relapsing multi…
• Nervous system disorder

Terlipressin

Terlipressin is a synthetic vasopressin analog that has been the subject of several clinical trials exploring its potential benefits in treating various medical conditions. This article examines the use of terlipressin in clinical trials for conditions such as portal hypertension, septic shock, hepatorenal syndrome, and surgical procedures like myomectomy. We’ll look at how terlipressin compares to other treatments and its effects on patient outcomes.

Related diseases and areas:

• Haemoptysis

Terlipressin Acetate

Terlipressin Acetate is a drug being studied in clinical trials for its potential benefits in treating cirrhosis, portal hypertension, and related complications such as refractory ascites. These trials aim to evaluate the safety, efficacy, and hemodynamic effects of Terlipressin when administered through different methods, including continuous infusion and bolus injection. The research focuses on how this medication impacts various aspects of liver and kidney function in patients with these conditions.

Related diseases and areas:

• Hepatorenal syndrome
• Sepsis
• Septic shock

Teropavimab

Teropavimab is an innovative drug currently being studied in clinical trials for the treatment of HIV-1 infection. This article explores the use of Teropavimab in combination with other medications to potentially provide long-acting treatment options for individuals with HIV-1. The trials aim to evaluate the safety, efficacy, and tolerability of Teropavimab when used alongside other drugs like Lenacapavir and Zinlirvimab in adults with suppressed HIV-1 viral loads.

Related diseases and areas:

• Acute HIV infection

Tertomotide

This article discusses a phase 2 clinical trial investigating the use of Tertomotide (GV1001) in treating mild to moderate Alzheimer’s disease. The study aims to assess the safety and efficacy of this drug when administered subcutaneously over a 52-week period. The trial is designed as a multicenter, randomized, double-blind, placebo-controlled study, focusing on cognitive improvements and overall patient function.

Related diseases and areas:

• Dementia Alzheimer’s type

Tetanus Toxoid Adsorbed On Aluminium Hydroxide, Hydrated And Aluminium Phosphate

This article examines clinical trials involving the use of tetanus toxoid adsorbed on aluminum hydroxide, hydrated and aluminum phosphate in combination vaccines. These trials aim to assess the safety, efficacy, and immune response of tetanus toxoid when administered alongside other vaccine components for protection against multiple diseases.

Related diseases and areas:

• Multiple sclerosis relapse
• Streptococcal infection

Tetracycline Hydrochloride

Tetracycline Hydrochloride, a widely used antibiotic, is being studied in various clinical trials for its potential benefits in treating different medical conditions. These trials aim to explore its effectiveness in preventing and treating infections, managing skin conditions, and even its possible role in cancer treatment. This article summarizes the key findings from recent clinical trials involving Tetracycline Hydrochloride, providing insights into its diverse applications in modern medicine.

Related diseases and areas:

• Osteoporosis

Tetrahydrouridine

Tetrahydrouridine (THU) is being studied in various clinical trials as a supportive drug to enhance the effectiveness of other cancer treatments. THU is often combined with drugs like decitabine or cytochlor to improve their absorption and distribution in the body. These trials aim to explore THU’s potential in treating different types of cancer, including lung cancer, blood disorders, and head and neck cancers.

Related diseases and areas:

• Sickle cell disease

TEV-53408

TEV-53408 is an investigational drug currently being studied in clinical trials for the treatment of autoimmune conditions including vitiligo and celiac disease. This medication is administered as a subcutaneous injection and aims to address the underlying immune responses in these conditions. Researchers are evaluating both the safety profile of TEV-53408 and its effectiveness in treating symptoms and improving quality of life for patients. The ongoing trials represent important steps toward potentially developing a new therapeutic option for patients with these challenging conditions.

Related diseases and areas:

• Coeliac disease

Teverelix

Teverelix TFA is a gonadotropin-releasing hormone (GnRH) antagonist currently being studied in clinical trials for its potential in treating advanced prostate cancer. This article explores the ongoing research on Teverelix TFA, including its pharmacokinetics, safety, and efficacy in both healthy volunteers and patients with prostate cancer.

Related diseases and areas:

• Prostate cancer

Tezacaftor

Tezacaftor is a promising drug being studied in clinical trials for the treatment of cystic fibrosis (CF). As part of combination therapies with other CF medications, tezacaftor aims to improve lung function and quality of life for people with specific CF genetic mutations. This article explores the ongoing research into tezacaftor’s effectiveness and safety for CF patients.

Related diseases and areas:

• Cystic fibrosis

Tezepelumab

Tezepelumab is an emerging biologic therapy being studied in clinical trials for the treatment of severe asthma. This article summarizes key findings from recent trials evaluating the efficacy and safety of tezepelumab in patients with inadequately controlled severe asthma. The trials examine outcomes such as asthma exacerbations, lung function, quality of life, and potential effects on the immune system.

Related diseases and areas:

• Chronic rhinosinusitis with…
• Asthma
• Eosinophilic oesophagitis
• Idiopathic pulmonary fibrosis
• Interstitial lung disease
• Chronic obstructive pulmona…

Thalidomide

Thalidomide, once infamous for its teratogenic effects, is now being investigated for its therapeutic potential in various medical conditions. This article explores recent clinical trials using thalidomide to treat a range of disorders, including beta-thalassemia, chronic radiation proctitis, syringomyelia, and hereditary hemorrhagic telangiectasia. These studies aim to evaluate the drug’s efficacy, safety, and potential benefits in managing these challenging conditions.

Related diseases and areas:

• Plasma cell myeloma
• Medulloblastoma
• Ependymoma

The-630

A new clinical trial is underway to assess the effectiveness and safety of THE-630, an oral medication designed to treat advanced gastrointestinal stromal tumors (GIST). This study aims to determine the optimal dosage and evaluate the drug’s ability to combat GIST in patients who have not responded well to previous treatments. The trial consists of two phases: a dose escalation phase to establish safety and appropriate dosing, followed by an expansion phase to further examine the drug’s effectiveness in different patient groups.

Related diseases and areas:

• Gastrointestinal stromal tu…

Theophylline

Theophylline, a medication traditionally used to treat respiratory conditions, is being investigated for its potential benefits in various medical conditions. Clinical trials are exploring its effects on bronchiectasis, syncope, diaphragmatic dysfunction, chronic obstructive pulmonary disease (COPD), and pseudohypoparathyroidism. These studies aim to evaluate theophylline’s efficacy, safety, and potential new applications in different patient populations.

Related diseases and areas:

• Heart disease congenital

Thiamazole

Thiamazole, also known as methimazole, is a medication primarily used to treat hyperthyroidism and Graves’ disease. This article explores recent clinical trials investigating the use of thiamazole in various medical conditions, including thyroid disorders and potential applications in other areas like cancer treatment. We’ll examine how researchers are studying its effects, dosing strategies, and potential benefits for patients.

Related diseases and areas:

• Graves’ disease

Thiamine

Thiamine, also known as vitamin B1, is being studied in several clinical trials for its potential benefits in various medical conditions. These trials aim to investigate the effects of thiamine supplementation on heart diseases, septic shock, critical illness, and cognitive function. Researchers are exploring how thiamine may improve patient outcomes, cardiac function, oxygen utilization, and overall health in different clinical scenarios.

Related diseases and areas:

• Huntington’s disease

Thiocolchicoside

Thiocolchicoside is a muscle relaxant drug that has been the subject of several clinical trials, particularly for its potential in treating various types of pain. These studies have explored its efficacy in conditions such as low back pain, neck pain, and temporomandibular disorders. The trials have investigated different formulations of thiocolchicoside, including oral tablets, injections, and topical applications, often in combination with other pain-relieving medications.

Related diseases and areas:

• Back pain

Thiotepa

Thiotepa, an alkylating agent with potent antitumor and immunosuppressive properties, is being extensively studied in clinical trials for its efficacy in various cancer treatments and stem cell transplantation procedures. This article explores the ongoing research on Thiotepa’s use in different medical conditions, its potential benefits, and the challenges associated with its administration.

Related diseases and areas:

• Mantle cell lymphoma stage III
• Medulloblastoma
• Retinoblastoma
• Diffuse large B-cell lymphoma
• Neuroblastoma
• Acute lymphocytic leukaemia

Threonine

This article provides an overview of clinical trials investigating the use of threonine, an essential amino acid, in treating different medical conditions. These trials aim to evaluate the safety and efficacy of threonine-containing medications in patients with pulmonary arterial hypertension, short bowel syndrome, and other disorders. The studies explore various formulations and combinations of threonine with other substances to optimize treatment outcomes.

Related diseases and areas:

• Peritonitis
• Oesophagectomy
• Intestinal infarction
• Intestinal obstruction
• Laparotomy

Thymalfasin

Thymalfasin, also known as thymosin alpha 1, is a synthetic peptide being investigated in clinical trials for its potential therapeutic effects in various medical conditions. This article summarizes key findings from recent clinical trials exploring the use of thymalfasin in diseases such as COVID-19, cancer, HIV, and sepsis. The trials aim to evaluate thymalfasin’s ability to modulate the immune system and potentially improve patient outcomes across different disease states.

Related diseases and areas:

• Cystic fibrosis

Tianeptine Sodium

This article discusses a clinical trial investigating the use of Tianeptine Sodium, an atypical antidepressant, for treating patients with Treatment Resistant Depression (TRD). The study aims to evaluate the effectiveness of Tianeptine in patients who have not responded to previous antidepressant treatments and to explore its unique mechanism of action involving the opioid system.

Related diseases and areas:

• Post-acute COVID-19 syndrome